News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Chromatin, Inc. Closes New Financing Round, Adds Private Equity Investors



1/9/2014 10:15:11 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CHICAGO--(BUSINESS WIRE)--Chromatin, Inc., an agriculture technology company, today announced the first closing of its Series E financing round, expected to total $36 million. Wood Creek Capital Management, an investment manager focused on investing in real assets and intellectual property, including agricultural resources, led the round. Other participants included GE Capital, Equity, as well as funds that had participated in earlier rounds of financing: BP Alternative Energy, IllinoisVentures, the State of Wisconsin Investment Board, and Adventures IV, LLC. With its Series E round, Chromatin has successfully raised over $70 million of equity in aggregate.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES